Status:
COMPLETED
Effectiveness of Colchicine Among Patients With COVID-19 Infection
Lead Sponsor:
Hawler Medical University
Conditions:
Coronavirus Infection
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
In November 2019, there were a lot of cases of an acute respiratory illness (then named at February 11th as COVID\_19) which first case was reported in Wuhan, China,The SARS COV-2 had been spread in a...
Detailed Description
this is an open label, randomize control clinical trial ,the participant will be randomly assign in to two groups ( Group A and Group B), colchicine (group A) will treat with colchicine tablet alone o...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients diagnosed clinically or by RT-PCR in nasopharyngeal swab specimens and/ or lung involvement confirm by computed tomography scan compatible with COVID-19patients 2.Age between 18 year and 70 years, 3.body weight \> 50 kg, 4.with written informed consent from patients or relatives.
- \-
- Exclusion Criteria 1 sensitivity to any medications of regimens, 2.e GFR less than 30. 3.pregnancy. 4.malignancy . 5.Participating in another clinical study and refusing to participate in the study at a later date or later, and they are already taking colchicine for other diseases .
- \-
Exclusion
Key Trial Info
Start Date :
May 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 18 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04867226
Start Date
May 8 2021
End Date
June 18 2021
Last Update
June 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hawler medical university ,Rozhawa emergency hospital
Erbil, Iraq, 44001